Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib/II Clinical Trial of the XELOX Regimen Combined With Sintilimab and Hyperbaric Oxygen Therapy for the Treatment of Advanced or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

NCT06742411 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT06742411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06742411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib/II Clinical Trial of the XELOX Regimen Combined With Sintilimab and Hyperbaric Oxygen Therapy for the Treatment of Advanced or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Lead sponsor
West China Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
December 31, 2024
Completion date
December 31, 2026
Enrollment
57 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastric (stomach) cancer